As new studies shed light on the benefits of these powerful plant compounds, terpenes could become the biggest thing in wellness since CBD. Here to tell us more is Kevin Koby, co-founder and Chief Science Officer of Abstrax Tech.

Learn more at https://abstraxtech.com 

Key Takeaways:

[1:03] Kevin's background in chemistry and how he came to start Abstrax

[1:55] An inside look at Abstrax Tech, the leading innovator in terpene sensorial experience

[2:44] A breakdown of terpenes and how this segment has evolved over the last couple of years

[4:44] How terpenes enhance the flavor and effects of cannabis through the entourage effect

[6:51] Abstrax's Type 7 licensed lab testing versus standard cannabis testing

[10:50] Exciting takeaways from Abstrax's "Man vs. Machine" experiment with Max Montrose

[14:02] How Abstrax's terpene research is taking cannabis to new heights

[17:07] Abstrax's terpene infusion products and the biggest trends Kevin sees among wholesale clients

[20:32] Where Kevin sees the terpene market heading over the next 3-5 years